Group 1 - Marsh (MRSH) shares increased by 3.3% to close at $176.48, following a notable trading volume compared to typical sessions, despite a 4.5% loss over the past four weeks [1] - The Mercer unit of Marsh has agreed to acquire AltamarCAM, adding €20 billion in assets under management, which enhances its presence in Europe and Latin America and supports its global private markets strategy [2] - The company is expected to report quarterly earnings of $3.22 per share, reflecting a year-over-year increase of 5.2%, with revenues projected at $7.39 billion, up 4.6% from the previous year [3] Group 2 - Trends in earnings estimate revisions are strongly correlated with near-term stock price movements, indicating that earnings growth expectations can signal potential stock strength [4] - The consensus EPS estimate for Marsh has been revised 0.7% lower in the last 30 days, suggesting that a negative trend in earnings estimate revisions may hinder price appreciation [5] - Marsh currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook within the Zacks Business - Services industry [6] Group 3 - AMN Healthcare, another company in the same industry, has seen its consensus EPS estimate rise by 2238.1% over the past month to $1.64, representing a 264.4% increase from the previous year [7]

Core Viewpoint - Marsh (MRSH) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the earnings report expected on January 29, 2026 [1][2]. Earnings Expectations - The consensus estimate for Marsh's quarterly earnings is $1.97 per share, reflecting a year-over-year increase of 5.4%, while revenues are projected to be $6.52 billion, up 7.4% from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 0.35%, indicating a reassessment by analysts regarding the company's earnings prospects [4]. Earnings Surprise Prediction - The Zacks Earnings ESP for Marsh is -0.02%, suggesting that the Most Accurate Estimate is lower than the Zacks Consensus Estimate, which indicates a bearish outlook from analysts [12]. Historical Performance - In the last reported quarter, Marsh exceeded the expected earnings of $1.79 per share by delivering $1.85, resulting in a surprise of 3.35%. The company has beaten consensus EPS estimates in all of the last four quarters [13][14]. Investment Considerations - Despite the potential for an earnings beat, other factors may influence stock movement, and the current Zacks Rank for Marsh is 3, making it challenging to predict a definitive earnings beat [15][17].